Avatrombopag Plus Fostamatinib Combination Efficacy and Safety in Patients with Immune Thrombocytopenia

被引：0
|
作者：
Mingot Castellano, Maria Eva [1 ]
Pedrote Amador, Begona [1 ]
Tomasello, Riccardo [2 ,3 ,4 ]
Ghanima, Waleed [4 ,5 ]
机构：
[1] Hosp Univ Virgen del Rocio, Inst Biomed Sevilla, IBIS, Serv Hematol, Seville, Spain
[2] Univ Oslo, Ostfold Hosp, Dept Res, Oslo, Norway
[3] Univ Oslo, Ostfold Hosp, Dept Haematooncol, Oslo, Norway
[4] Univ Oslo, Inst Clin Med, Oslo, Norway
[5] Univ Oslo, Ostfold Hosp, Oslo, Norway
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-187518
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Efficacy and Safety of Avatrombopag in the Treatment of Thrombocytopenia after Umbilical Cord Blood Transplantation
    Huang, Aijie
    Sun, Guangyu
    Tang, Baolin
    Song, Kaidi
    Cheng, Yaxin
    Tu, Meijuan
    Wu, Yue
    Pan, Tianzhong
    Wang, Dongyao
    Zhu, Xiaoyu
    BLOOD, 2023, 142
  • [22] Efficacy and Safety of Avatrombopag in Patients With Thrombocytopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Li, Chunlu
    Li, Xiaoxuan
    Huang, Feihong
    Yang, Jing
    Wu, Anguo
    Wang, Long
    Qin, Dalian
    Zou, Wenjun
    Wu, Jianming
    FRONTIERS IN PHARMACOLOGY, 2019, 10
  • [23] The efficacy and safety of avatrombopag in the treatment of thrombocytopenia secondary to targeted and immunotherapy in hepatocellular carcinoma
    Peng, X.
    Wu, K.
    Wang, L.
    Wang, Z.
    You, N.
    Zhang, H.
    Liu, Z.
    Zheng, L.
    ANNALS OF ONCOLOGY, 2024, 35 : S1491 - S1491
  • [24] Addressing thrombosis concerns in immune thrombocytopenia: the role of fostamatinib in immune thrombocytopenia management
    Provan, Drew
    Thachil, Jecko
    Roman, Maria Teresa alvarez
    EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (1-3) : 55 - 66
  • [25] Efficacy and safety of avatrombopag in Chinese children with persistent and chronic primary immune thrombocytopenia: A multicentre observational retrospective study in China
    Wang, Zhifa
    Zhang, Aijun
    Xu, Zhongjin
    Wang, Nan
    Zhang, Jialu
    Meng, Jinxi
    Dong, Shuyue
    Ma, Jingyao
    Hu, Yu
    Ouyang, Juntao
    Chen, Zhenping
    An, Qi
    Cheng, Xiaoling
    Wu, Runhui
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 204 (05) : 1958 - 1965
  • [26] Fostamatinib is an effective second-line therapy in patients with immune thrombocytopenia
    Boccia, Ralph
    Cooper, Nichola
    Ghanima, Waleed
    Boxer, Michael A.
    Hill, Quentin A.
    Sholzberg, Michelle
    Tarantino, Michael D.
    Todd, Leslie K.
    Tong, Sandra
    Bussel, James B.
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (06) : 933 - 938
  • [27] Evaluating fostamatinib disodium as a treatment option for immune thrombocytopenia in adult patients
    Dierickx, Daan
    Neefs, Jens
    EXPERT OPINION ON PHARMACOTHERAPY, 2022, 23 (08) : 885 - 892
  • [28] Avatrombopag for the treatment of immune thrombocytopenia and thrombocytopenia of chronic liver disease
    Cheloff, Abraham Z.
    Al-Samkari, Hanny
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 313 - 321
  • [29] The efficacy and safety of romiplostim in adult patients with chronic immune thrombocytopenia
    Cooper, Nichola
    Terrinoni, Ilaria
    Newland, Adrian
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2012, 3 (05) : 291 - 298
  • [30] The efficacy and safety of eltrombopag in Chinese patients with chronic immune thrombocytopenia
    黄月婷
    ChinaMedicalAbstracts(InternalMedicine), 2018, 35 (01) : 54 - 55
12345